Antimicrobial resistance is an important factor shaping treatment protocols and research priorities in the United States. Healthcare institutions use infection surveillance, diagnostic testing, and stewardship practices to guide appropriate medicine selection. Market developments are also influenced by pharmaceutical innovation, insurance and reimbursement arrangements, drug availability, and...